Zevra Therapeutics (ZVRA) Prepaid Assets (2014 - 2026)
Zevra Therapeutics (ZVRA) posted Prepaid Assets of $4.9 million for Q1 2026, down 29.35% on a QoQ basis from $7.0 million in Q4 2025, and up 31.28% year-over-year from $3.8 million in Q1 2025.
Zevra Therapeutics (ZVRA) Prepaid Assets (2014 - 2026) Analysis & Trends
Zevra Therapeutics' Prepaid Assets history runs 13 years deep, the most recent figure standing at $4.9 million for Q1 2026.
- Quarterly Prepaid Assets rose 31.28% year-over-year to $4.9 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $4.9 million (up 31.28% YoY) and the FY2025 annual result came in at $7.0 million, up 72.7% from the prior year.
- Prepaid Assets was $4.9 million for Q1 2026 at Zevra Therapeutics, down from $7.0 million in the prior quarter.
- Across five years, Prepaid Assets topped out at $7.4 million in Q3 2025 and bottomed at -$426000.0 in Q2 2022.
- A 5-year average of $2.8 million and a median of $2.3 million in 2024 frame the typical range for Prepaid Assets.
- Annual changes were most pronounced in 2022 — Prepaid Assets tumbled 128.25% — and 2023, when it surged 489.91%.
- Zevra Therapeutics' Prepaid Assets stood at $1.7 million in 2022, then sank by 30.57% to $1.2 million in 2023, then soared by 245.73% to $4.1 million in 2024, then surged by 72.7% to $7.0 million in 2025, then dropped by 29.35% to $4.9 million in 2026.
- Business Quant data shows ZVRA's Prepaid Assets at $4.9 million in Q1 2026, $7.0 million in Q4 2025, and $7.4 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Zevra Therapeutics | 239.71 Mn | 39.10 Mn | 34.32 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 4.94 Mn |
| Dec 31, 2025 | 7.00 Mn |
| Sep 30, 2025 | 7.40 Mn |
| Jun 30, 2025 | 4.35 Mn |
| Mar 31, 2025 | 3.77 Mn |
| Dec 31, 2024 | 4.05 Mn |
| Sep 30, 2024 | 2.28 Mn |
| Jun 30, 2024 | 2.69 Mn |
| Mar 31, 2024 | 1.87 Mn |
| Dec 31, 2023 | 1.17 Mn |
| Sep 30, 2023 | 1.66 Mn |
| Dec 31, 2022 | 1.69 Mn |
| Sep 30, 2022 | -426,000.00 |
| Jun 30, 2022 | -426,000.00 |
| Mar 31, 2022 | 454,000.00 |
| Dec 31, 2021 | 637,000.00 |
| Sep 30, 2021 | 1.51 Mn |
| Jun 30, 2021 | 2.00 Mn |
| Mar 31, 2021 | 395,000.00 |
| Dec 31, 2020 | 1.48 Mn |